Insights
More Articles
- India withdraws export ban on antimalarial drug
- EU OKs SARS-CoV-2 kit from Genetron Health
- Aid Genomics, BGI partner to build coronavirus testing lab
- Study tests ivermectin in lab-grown COVID-19 cells
- Dosing begins in trial of blood cancer CAR T-cell therapy
India withdraws export ban on antimalarial drug
India's partial ban on exports of antimalarial drug hydroxychloroquine, which was repeatedly touted by President Donald Trump as a potential coronavirus treatment, has been lifted. The move follows threat of retaliation by Trump. Business Insider (4/7)
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!